Vaccination with anti-coronavirus vaccines from Pfizer-BioNTech and Moderna was 94% effective against hospitalization with COVID-19 in fully immunized people ≥65 years of age. This is reported in a press release by the US Centers for Disease Control and Prevention (CDC).
In addition, a single dose of these mRNA vaccines resulted in 64 percent protection against admission to the hospital for those vaccinated in the same age group.
The effectiveness of vaccinations was checked using data from January 1 to March 26 in 24 hospitals in 14 states, analyzing the rates of 417 hospitalized (mean age 73 years, 48% women).
Among the 187 cases, 18 received one dose of vaccine ≥14 days before the onset of illness, and one to two.
See also: How COVID-19 breaks through the “full protection” of the vaccinated: a study from the United States
Adults 65 and older are at increased risk of severe COVID-19 outcomes. This group has been identified as a priority vaccine worldwide. Since the beginning of December, over 1 billion doses of anti-coronavirus vaccines have been administered.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
